The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.
Collin G. Wolf, BS
Advertisement
Articles by Collin G. Wolf, BS
Advertisement
Latest Updated Articles
- Pricing of Monoclonal Antibody Therapies: Higher If Used for Cancer?
February 14th 2018
Advertisement
Advertisement
Trending on AJMC
1
Patient Portal Messages Outpace Office Visits
2
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
3
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
4
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
5